Numerous active ingredients have already been tried against the corona virus.
So far, only one age-old bestseller has really convinced - the cortisone preparation dexamethasone.
The last remaining hopes are therefore currently the so-called monoclonal antibodies.
Two such drugs have just been approved in the United States.
The virologist and antibody expert Florian Klein from Cologne University Hospital explains whether the hopes are justified.
WORLD:
In the USA, the artificial antibodies from Regeneron and Eli Lilly have just been approved.
The means that Donald Trump believes saved his life.
Europe is likely to follow soon.
What does the expert say: are they really that promising?
Florian Klein:
Yes, in my opinion yes.
We know from other viral infections that antibodies can slow down the reproduction of pathogens - this is a very promising approach, especially in the initial phase of an infection.